Buprenorphine treatment with and without induction was found to decrease costs and utilization in opioid-dependent benefciaries.
Liana D. Castel, PhD
Advertisement
Articles by Liana D. Castel, PhD
Advertisement
Latest Updated Articles
- Clinical and Cost Outcomes of Buprenorphine Treatment in a Commercial Benefit Plan Population
Published: February 2nd 2018 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Lynkuet Access Program Aims to Help Women Save on Neurokinin-Targeted Therapy
2
Fall 2025 Quiz: Test Your Pharmacy Knowledge!
3
FDA Approves Blenrep for Treatment of Relapsed or Refractory Multiple Myeloma
4
Hormone Therapy Use, Understanding, and Perceptions Have Positively Shifted From 2021 to 2025
5
